Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Arris/Merck & Co. osteoporosis collaboration

Nov. 21, 1996

French market introduction for Fractal

Nov. 21, 1996

HRT for preserving bone density in postmenopausal women

Nov. 20, 1996

Immunoregulating effect of IL-4 in IDDM

Nov. 20, 1996

Pharming granted orphan drug status for Pompe's disease therapy

Nov. 20, 1996

Warner-Lambert claims lipid-regulating agents for vascular disease, diabetes

Nov. 20, 1996

FDA approves treatment for homocystinuria

Nov. 19, 1996

Growth stimulant reported by American Cyanamid

Nov. 19, 1996

Second NDA submitted for Crinone

Nov. 15, 1996

Lilly reports agents to treat menopause-related conditions

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...